Steven Quentzel, Associate Partner, will attend the 9th Annual Congress of the European Association for Haemophilia and Allied Disorders on February 3-5, 2016 in Malmö, Sweden.
Steven is an experienced medical affairs consultant with over 20 years in the pharmaceutical industry. He has held various senior medical affairs positions for late stage clinical trials in Thrombosis, Cardiology and Diabetes.
The 9th Annual Congress of the European Association for Haemophilia and Allied Disorders will cover topics including the immunology and genetics of haemophila, current aspects of haemophilia and future perspectives in the disease.